These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20216236)

  • 1. Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization.
    Zuppa AA; Alighieri G; Calabrese V; Visintini F; Cota F; Carducci C; Antichi E; Noia GA; Fortunato G; Romagnoli C
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e95-101. PubMed ID: 20216236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant erythropoietin in the prevention of late anaemia in intrauterine transfused neonates with Rh-haemolytic disease.
    Zuppa AA; Maragliano G; Scapillati ME; Florio MG; Girlando P; Noia G; De Santis M; Cavaliere AF; Romagnoli C; Tortorolo G
    Fetal Diagn Ther; 1999; 14(5):270-4. PubMed ID: 10529568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between two treatment protocols with recombinant human erythropoietin (rHuEpo) in the treatment of late anemia in neonates with Rh-isoimmunization.
    Zuppa AA; Alighieri G; Fracchiolla A; Catenazzi P; D'Antuono A; Riccardi R; Cavani M; Romagnoli C
    Pediatr Med Chir; 2012; 34(4):186-91. PubMed ID: 23173411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Rh(c), "little c," isoimmunization: the role of rHuEpo in preventing late anemia.
    Zuppa AA; Cardiello V; Alighieri G; Cota F; D'Antuono A; Riccardi R; Catenazzi P; Romagnoli C
    J Pediatr Hematol Oncol; 2013 Aug; 35(6):e269-71. PubMed ID: 23073047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
    al-Alaiyan S; al Omran A
    J Perinat Med; 1999; 27(2):112-5. PubMed ID: 10379500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin as treatment for late hyporegenerative anemia in neonates with Rh hemolytic disease after in utero exchange transfusion.
    Nicaise C; Gire C; Casha P; d'Ercole C; Chau C; Palix C
    Fetal Diagn Ther; 2002; 17(1):22-4. PubMed ID: 11803211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
    Ovali F; Samanci N; Dağoğlu T
    Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant erythropoietin as treatment for hyporegenerative anemia following hemolytic disease of the newborn].
    Donato H; Bacciedoni V; García C; Schvartzman G; Vain N
    Arch Argent Pediatr; 2009 Apr; 107(2):119-25. PubMed ID: 19452083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis.
    Kotto-Kome AC; Garcia MG; Calhoun DA; Christensen RD
    J Perinatol; 2004 Jan; 24(1):24-9. PubMed ID: 14726934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
    De Boer IP; Zeestraten EC; Lopriore E; van Kamp IL; Kanhai HH; Walther FJ
    Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
    Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
    J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
    Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
    An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization.
    Millard DD; Gidding SS; Socol ML; MacGregor SN; Dooley SL; Ney JA; Stockman JA
    J Pediatr; 1990 Sep; 117(3):447-54. PubMed ID: 2118174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
    Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF
    Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.